Literature DB >> 27199449

Bone Morphogenetic Protein Signaling Is Required for Aortic Valve Calcification.

M Victoria Gomez-Stallons1, Elaine E Wirrig-Schwendeman1, Keira R Hassel1, Simon J Conway1, Katherine E Yutzey2.   

Abstract

OBJECTIVE: Calcific aortic valve disease (CAVD) is the most prevalent type of heart valve disease, affecting ≈2% of the US population. CAVD is characterized by the presence of calcific nodules, resulting in aortic valve (AoV) stenosis; however, the underlying mechanisms driving disease remain unknown. Studies of human diseased AoV provide initial evidence that bone morphogenetic protein (BMP) signaling, essential for normal bone formation, is activated during CAVD. Mice deficient in Klotho, an FGF23 transmembrane coreceptor, exhibit premature aging and develop AoV calcific nodules as occurs in human CAVD. The role of BMP signaling in the development of CAVD was examined in porcine aortic valve interstitial cells (VICs) and Klotho(-/-) mice. APPROACH AND
RESULTS: We show that activation of BMP signaling, as indicated by pSmad1/5/8 expression, precedes and later localizes with AoV calcification in Klotho(-/-) mice. In addition, cellular and extracellular matrix changes resembling features of normal bone formation are accompanied by increased osteochondrogenic gene induction in calcified Klotho(-/-) AoV. Likewise, osteogenic media treatment of porcine VICs results in BMP pathway activation, increased osteochondrogenic gene induction, and formation of calcific nodules in vitro. We demonstrate that genetic inactivation of the BMP type IA receptor in Klotho(-/-) aortic VICs, as well as BMP pathway inhibition of osteogenic media-treated aortic VICs in vitro, results in the inhibition of AoV calcification.
CONCLUSIONS: BMP signaling and osteochondrogenic gene induction are active in calcified Klotho(-/-) AoV in vivo and calcified porcine aortic VICs in vitro. Importantly, BMP signaling is required for the development of AoV calcification in vitro and in vivo.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  BMP; Klotho; aortic valve calcification; heart valve disease; osteogenesis

Mesh:

Substances:

Year:  2016        PMID: 27199449      PMCID: PMC4919184          DOI: 10.1161/ATVBAHA.116.307526

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  44 in total

1.  COX2 inhibition reduces aortic valve calcification in vivo.

Authors:  Elaine E Wirrig; M Victoria Gomez; Robert B Hinton; Katherine E Yutzey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02-26       Impact factor: 8.311

2.  Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study.

Authors:  Jason P Linefsky; Kevin D O'Brien; Ronit Katz; Ian H de Boer; Eddy Barasch; Nancy S Jenny; David S Siscovick; Bryan Kestenbaum
Journal:  J Am Coll Cardiol       Date:  2011-07-12       Impact factor: 24.094

3.  Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling.

Authors:  Lili Zhou; Yingjian Li; Dong Zhou; Roderick J Tan; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2013-04-04       Impact factor: 10.121

4.  Loss of β-catenin promotes chondrogenic differentiation of aortic valve interstitial cells.

Authors:  Ming Fang; Christina M Alfieri; Alexia Hulin; Simon J Conway; Katherine E Yutzey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-23       Impact factor: 8.311

5.  The congenitally bicuspid aortic valve. A study of 85 autopsy cases.

Authors:  W C Roberts
Journal:  Am J Cardiol       Date:  1970-07       Impact factor: 2.778

6.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing.

Authors:  M Kuro-o; Y Matsumura; H Aizawa; H Kawaguchi; T Suga; T Utsugi; Y Ohyama; M Kurabayashi; T Kaname; E Kume; H Iwasaki; A Iida; T Shiraki-Iida; S Nishikawa; R Nagai; Y I Nabeshima
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

Review 7.  Molecular mechanisms of vascular calcification: lessons learned from the aorta.

Authors:  Jian-Su Shao; Jun Cai; Dwight A Towler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-06       Impact factor: 8.311

8.  Prosthetic heart valves: catering for the few.

Authors:  Peter Zilla; Johan Brink; Paul Human; Deon Bezuidenhout
Journal:  Biomaterials       Date:  2007-10-24       Impact factor: 12.479

Review 9.  The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis.

Authors:  M Shawkat Razzaque
Journal:  Nat Rev Endocrinol       Date:  2009-11       Impact factor: 43.330

10.  Augmented Wnt signaling in a mammalian model of accelerated aging.

Authors:  Hongjun Liu; Maria M Fergusson; Rogerio M Castilho; Jie Liu; Liu Cao; Jichun Chen; Daniela Malide; Ilsa I Rovira; Daniel Schimel; Calvin J Kuo; J Silvio Gutkind; Paul M Hwang; Toren Finkel
Journal:  Science       Date:  2007-08-10       Impact factor: 47.728

View more
  32 in total

1.  Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis.

Authors:  Rihab Bouchareb; Marie-Chloé Boulanger; Lionel Tastet; Ghada Mkannez; Mohamed J Nsaibia; Fayez Hadji; Abdellaziz Dahou; Younes Messadeq; Benoit J Arsenault; Philippe Pibarot; Yohan Bossé; André Marette; Patrick Mathieu
Journal:  Eur Heart J       Date:  2019-05-01       Impact factor: 29.983

2.  Genetic basis of aortic valvular disease.

Authors:  Sara N Koenig; Joy Lincoln; Vidu Garg
Journal:  Curr Opin Cardiol       Date:  2017-05       Impact factor: 2.161

3.  Klotho suppresses high phosphate-induced osteogenic responses in human aortic valve interstitial cells through inhibition of Sox9.

Authors:  Fei Li; Qingzhou Yao; Lihua Ao; Joseph C Cleveland; Nianguo Dong; David A Fullerton; Xianzhong Meng
Journal:  J Mol Med (Berl)       Date:  2017-03-22       Impact factor: 4.599

Review 4.  Mineral metabolism and cardiovascular disease in CKD.

Authors:  Hideki Fujii; Nobuhiko Joki
Journal:  Clin Exp Nephrol       Date:  2017-01-06       Impact factor: 2.801

5.  Hypoxia promotes primitive glycosaminoglycan-rich extracellular matrix composition in developing heart valves.

Authors:  Dorothy Amofa; Alexia Hulin; Yuji Nakada; Hesham A Sadek; Katherine E Yutzey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-25       Impact factor: 4.733

Review 6.  Mechanisms of heart valve development and disease.

Authors:  Anna O'Donnell; Katherine E Yutzey
Journal:  Development       Date:  2020-07-03       Impact factor: 6.868

7.  Maturation of heart valve cell populations during postnatal remodeling.

Authors:  Alexia Hulin; Luis Hortells; M Victoria Gomez-Stallons; Anna O'Donnell; Kashish Chetal; Mike Adam; Patrizio Lancellotti; Cecile Oury; S Steven Potter; Nathan Salomonis; Katherine E Yutzey
Journal:  Development       Date:  2019-03-12       Impact factor: 6.868

8.  BMP2 expression in the endocardial lineage is required for AV endocardial cushion maturation and remodeling.

Authors:  Jacob G Saxon; Daniel R Baer; Julie A Barton; Travis Hawkins; Bingruo Wu; Thomas C Trusk; Stephen E Harris; Bin Zhou; Yuji Mishina; Yukiko Sugi
Journal:  Dev Biol       Date:  2017-08-06       Impact factor: 3.582

9.  Reporting Sex and Sex Differences in Preclinical Studies.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

10.  Endothelial Cell Lineage Analysis Does Not Provide Evidence for EMT in Adult Valve Homeostasis and Disease.

Authors:  Andrew J Kim; Christina M Alfieri; Katherine E Yutzey
Journal:  Anat Rec (Hoboken)       Date:  2018-10-10       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.